search
Back to results

Blood Glucose Control With A Software-Algorithm In Intensive Care Unit (ICU) Patients (Aldea _01)

Primary Purpose

Critical Illness

Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
enhanced model predictive control algorithm (eMPC)
Sponsored by
B. Braun Melsungen AG
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Critical Illness focused on measuring algorithm, tight glycemic control, glucose control, intensive care, insulin, ICU

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age: > 18 years of age
  • Stay in the ICU expected to be > 120 h
  • Blood glucose > 110 mg/dl or patient on insulin treatment

Exclusion Criteria:

  • Patients with hyperglycaemic crisis/ketoacidosis due to insulin deficiency.
  • Known or suspected allergy to insulin
  • Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient (i.e., liver failure, other fatal organ failures)
  • Moribund patients likely to die within 24 hours

Sites / Locations

  • Medical University Graz

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

A

Arm Description

improved model predictive control algorithm (eMPC) for glycaemic control in ICU patients

Outcomes

Primary Outcome Measures

percentage of time within the predefined glucose target range of 80-110 mg/dL

Secondary Outcome Measures

hypoglycemias (lab) and possible attendant clinical symptoms (e.g. convulsions)
Usability parameters like convenience of alarming function; workload; blood sampling frequency
Concomitant medication including insulin infusion rate, parenteral/enteral nutrition

Full Information

First Posted
August 13, 2008
Last Updated
April 15, 2009
Sponsor
B. Braun Melsungen AG
search

1. Study Identification

Unique Protocol Identification Number
NCT00735163
Brief Title
Blood Glucose Control With A Software-Algorithm In Intensive Care Unit (ICU) Patients
Acronym
Aldea _01
Official Title
Mono-Centric, Open, Non-Controlled Study To Investigate The Feasibility Of Blood Glucose Control With The Software-Algorithm eMPC (Enhanced Model Predictive Control) In ICU Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2009
Overall Recruitment Status
Completed
Study Start Date
September 2008 (undefined)
Primary Completion Date
February 2009 (Actual)
Study Completion Date
February 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
B. Braun Melsungen AG

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Hyperglycemia is common in critically ill patients and associated with an adverse outcome. Recently, large randomized controlled trials have demonstrated that tight glycaemic control (TGC) reduces morbidity and mortality in this population. Based on this emerging evidence intensive insulin therapy is currently finding its way into the critical care practice. In the meantime numerous insulin infusion protocols, which are based on frequent bedside glucose monitoring, have been implemented. Recent reviews comparing different types of protocols describe widely ranging practice and difficulties in achieving TGC despite extensive efforts of the intensive care unit (ICU) staff. A fully automated algorithm may help to overcome some of these limitations by excluding intuitive interventions and integrating relevant clinical data in the decision-making process. The primary objective of the current study is to investigate the performance (efficacy) of a control algorithm for glycaemic control in ICU patients for the whole length of ICU stay.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness
Keywords
algorithm, tight glycemic control, glucose control, intensive care, insulin, ICU

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Experimental
Arm Description
improved model predictive control algorithm (eMPC) for glycaemic control in ICU patients
Intervention Type
Other
Intervention Name(s)
enhanced model predictive control algorithm (eMPC)
Intervention Description
eMPC (software on a bedside computer) advised insulin titration to establish tight glycaemic control
Primary Outcome Measure Information:
Title
percentage of time within the predefined glucose target range of 80-110 mg/dL
Time Frame
from start of treatment to the last glucose measurement under treatment
Secondary Outcome Measure Information:
Title
hypoglycemias (lab) and possible attendant clinical symptoms (e.g. convulsions)
Time Frame
from start of treatment to the last glucose measurement under treatment
Title
Usability parameters like convenience of alarming function; workload; blood sampling frequency
Time Frame
from start of treatment to the last glucose measurement under treatment
Title
Concomitant medication including insulin infusion rate, parenteral/enteral nutrition
Time Frame
from start of treatment to the last glucose measurement under treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age: > 18 years of age Stay in the ICU expected to be > 120 h Blood glucose > 110 mg/dl or patient on insulin treatment Exclusion Criteria: Patients with hyperglycaemic crisis/ketoacidosis due to insulin deficiency. Known or suspected allergy to insulin Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient (i.e., liver failure, other fatal organ failures) Moribund patients likely to die within 24 hours
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas R Pieber, Prof. Dr.
Organizational Affiliation
Medical University of Graz
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University Graz
City
Graz
ZIP/Postal Code
8036
Country
Austria

12. IPD Sharing Statement

Citations:
PubMed Identifier
16443872
Citation
Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R, Pieber TR. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care. 2006 Feb;29(2):271-6. doi: 10.2337/diacare.29.02.06.dc05-1689.
Results Reference
background
PubMed Identifier
18297268
Citation
Pachler C, Plank J, Weinhandl H, Chassin LJ, Wilinska ME, Kulnik R, Kaufmann P, Smolle KH, Pilger E, Pieber TR, Ellmerer M, Hovorka R. Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients. Intensive Care Med. 2008 Jul;34(7):1224-30. doi: 10.1007/s00134-008-1033-8. Epub 2008 Feb 23.
Results Reference
background

Learn more about this trial

Blood Glucose Control With A Software-Algorithm In Intensive Care Unit (ICU) Patients

We'll reach out to this number within 24 hrs